A shift to defensives like FMCG & pharma apparent: Rohit Srivastava
Rohit Srivastava, Founder, Indiacharts.com, says “there is room for more upside but not a runaway move. 44,800 may be the best case for Bank Nifty, for example, on the upside right now. We are not looking beyond that. That could happen post-Diwali, looking at the way the market is pausing at this level right now.”
Given that Nifty is range-bound and Nifty Bank again continues to appear to be weak, how are you looking at both the indices? Where can we find some breakout coming in both these indices?
I think above 19,450 is going to be the first hurdle that Nifty is facing. We are pretty close to that and once we get past that, we should head towards 19,700. Even in the Bank Nifty, we are very close to the 40-day average, which is at around 43,680. And above that, we can go towards maybe 43,800 or slightly higher than that also.
Unlock Leadership Excellence with a Range of CXO Courses
Offering CollegeCourseWebsiteIIM LucknowIIML Chief Executive Officer ProgrammeVisitIndian School of BusinessISB Chief Technology OfficerVisitIIM KozhikodeIIMK Chief Product Officer ProgrammeVisitSo there is room for more upside. Not a runaway move. 44,800 may be the best case for Bank Nifty, for example, on the upside right now. We are not looking beyond that. That should happen possibly post-Diwali, looking at the way the market is pausing at this level right now.
Momentum seems to be in favour when it comes to the pharma names and in fact, the index is also one of the top sectoral gainers, any specific stocks that you are looking at in the pharma index?
Broadly the pharma sector has underperformed for most of last year. So I think it is about time that there is some allocation. It is also that we are getting to the point where, if you
